FMO5 and cancer: Our previous study showed that the human orthologue of mouse CCL9, CCL15, promoted ROS to mediate the migration ability of cancer cells via p22phox, which is an essential subunit for the formation of functionally active NADPH oxidase [61], thus suggesting CCL9 can at least modulate the levels of intracellular ROS through NADPH oxidase [46].